Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 439

1.

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013.

McPherson T, Fontane P, Iyengar R, Henderson R.

J Manag Care Spec Pharm. 2016 Feb;22(2):172-81. doi: 10.18553/jmcp.2016.22.2.172.

2.

Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.

Khandelwal N, Duncan I, Rubinstein E, Ahmed T, Pegus C.

J Manag Care Pharm. 2012 Apr;18(3):247-55.

3.
4.
5.

Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?

Tungol A, Starner CI, Gunderson BW, Schafer JA, Qiu Y, Gleason PP.

J Manag Care Pharm. 2012 Nov-Dec;18(9):690-700.

7.

Health plan utilization and costs of specialty drugs within 4 chronic conditions.

Gleason PP, Alexander GC, Starner CI, Ritter ST, Van Houten HK, Gunderson BW, Shah ND.

J Manag Care Pharm. 2013 Sep;19(7):542-8.

9.

Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.

Pauly NJ, Talbert JC, Brown J.

J Manag Care Spec Pharm. 2016 Jun;22(6):741-51. doi: 10.18553/jmcp.2016.22.6.741.

10.

Prevalence and predictors of utilization of community pharmacy generic drug discount programs.

Gatwood J, Tungol A, Truong C, Kucukarslan SN, Erickson SR.

J Manag Care Pharm. 2011 Jul-Aug;17(6):449-55.

11.

Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.

Starner CI, Schafer JA, Heaton AH, Gleason PP.

J Manag Care Pharm. 2008 Jul-Aug;14(6):523-31.

12.

Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.

Delea TE, Gokhale M, Makin C, Hussein MA, Vanderpoel J, Sandman T, Chang J, Sung J, Pinkston P, Gause D, Jackson M.

J Manag Care Pharm. 2007 May;13(4):349-59.

13.
14.

Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.

Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ.

J Manag Care Pharm. 2009 Jan-Feb;15(1):18-31.

15.

Prescription drug costs and the generic dispensing ratio.

Liberman JN, Roebuck MC.

J Manag Care Pharm. 2010 Sep;16(7):502-6.

16.

Actuarial analysis of private payer administrative claims data for women with endometriosis.

Mirkin D, Murphy-Barron C, Iwasaki K.

J Manag Care Pharm. 2007 Apr;13(3):262-72.

17.

A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets.

Rubino M, Summers KH, Puenpatom A, Fu C, Ohsfeldt RL, Ben-Joseph RH.

J Manag Care Pharm. 2011 Jun;17(5):367-76.

18.
19.

Utilization, Cost, and Pricing Scheme of Compounded Medications for Public Health System Patients: The California Workers' Compensation System, 2011-2013.

Lin TK, Shoair OA, Tran D, Wilson L.

J Manag Care Spec Pharm. 2019 Jul;25(7):743-751. doi: 10.18553/jmcp.2019.25.7.743.

20.

Measuring economic impact of applying daily average consumption limits.

Flavin BM, Nishida LM, Karbowicz SH, Renner ME, Leonard RJ.

J Manag Care Pharm. 2014 Feb;20(2):159-64.

Supplemental Content

Support Center